Second-trimester genetic amniocentesis: 5-Yar experience

Archives of Gynecology and Obstetrics

Volumn 271, Issue 1, 2005, Pages 19-21

  Turhan, Nilgün Öztürk ^a   Eren, Ünal ^a   Seçkin, Neslihan Carda ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Amniocentesis; Anomaly screening; Prenatal diagnosis; Triple test; Ultrasonography

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CORPUS CALLOSUM AGENESIS; DOWN SYNDROME; EVALUATION; EXPERIENCE; FEMALE; FETUS WASTAGE; GASTROSCHISIS; GENETIC SCREENING; HOSPITAL DEPARTMENT; HOSPITAL PERSONNEL; HUMAN; LITERATURE; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL RECORD; NEWBORN; OMPHALOCELE; PREGNANCY COMPLICATION; RELIABILITY; SAFETY; SECOND TRIMESTER PREGNANCY; SIBLING; ULTRASOUND; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AMNIOCENTESIS; CHROMOSOME ABERRATIONS; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 12944302599     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0635-9     Document Type: Article

References (11)

1. Blessed WB, Lacoste H, Welch RA (2001) Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J Obstet Gynecol 184:1340-1344
2. Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group (1998) Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 351:242-247
3. Cuckle HS, Wald NJ, Thompson SG (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94:387-402
4. Gilbert RE (2001) Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 323:23-25
5. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA et al (1992) Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327:588-593
6. Hook EB (1981) Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 58:282-285
7. Kuller JA, Laifer SA (1995) Contemporary approaches to prenatal diagnosis. Am Fam Physician 52:2277-2283, 2285-2286
8. National Institute of Child Health and Human Development National Registry for Amniocentesis (NICHD) study group (1976) Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy. J Am Med Assoc 236:1471-1476
9. Reid KP, Gurrin LC, Dickinson JE, Newnham JP, Phillips JM (1999) Pregnancy loss rates following second trimester genetic amniocentesis. Aust NZJ Obstet Gynaecol 39:281-285
10. Wald NJ (1996) Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Br J Obstet Gynaecol 103:407-412
11. Wald NJ, Kennard A, Hackshaw A, McGuire A (1997) Antenatal screening for Down's syndrome. J Med Screen 4:181-246